Resistance to TGF-β1 correlates with a reduction of TGF-β type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines

Journal of General Virology

Volumn 81, Issue 6, 2000, Pages 1567-1578

  Inman, Gareth J ^a   Allday, Martin J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RECEPTOR SUBTYPE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; DNA; DNA BINDING PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; POLYADENYLIC ACID; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC RESISTANCE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; BIOSYNTHESIS; CELL DIVISION; CELL LINE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; MUTAGENESIS; VIRUS LATENCY;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

APOPTOSIS; BURKITT LYMPHOMA; CELL DIVISION; CELL LINE, TRANSFORMED; DNA; DNA-BINDING PROTEINS; DRUG RESISTANCE; G1 PHASE; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; MUTAGENESIS; POLY A; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

EID: 0033625354     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-6-1567     Document Type: Article

References (52)

1. Allday, M. J. & Farrell, P. J. (1994). Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells. Journal of Virology 68, 3491-3498.
2. Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H. & Farrell, P. J. (1995). Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO Journal 14, 1382-1391.
3. Altiok, A., Ehlin-Henriksson, B. & Klein, E. (1993). Correlation between the growth-inhibitory effect of TGF-beta 1 and phenotypic characteristics in a panel of B-cell lines. International Journal of Cancer 55, 137-140.
4. Amoroso, S. R., Huang, N., Roberts, A. B., Potter, M. & Letterio, J. J. (1998). Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas. Proceedings of the National Academy of Sciences, USA 95, 189-194.
5. Arvanitakis, L., Yaseen, N. & Sharma, S. (1995). Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Journal of Immunology 155, 1047-1056.
6. Bauer, G., Hofler, P. & Simon, M. (1982). Epstein-Barr virus induction by a serum factor. Characterization of the purified factor and the mechanism of its activation. Journal of Biological Chemistry 257, 11411-11415.
7. Beckwith, M., Ruscetti, F. W., Sing, G. K., Urba, W. J. & Longo, D. L. (1995). Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: inhibition of growth is associated with a downregulation of mutant p53. Blood 85, 2461-2470.
8. Blomhoff, H. K., Smeland, E., Mustafa, A. S., Godal, T. & Ohlsson, R. (1987). Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage. European Journal of Immunology 17, 299-301.
9. Brimmell, M., Mendiola, R., Mangion, J. & Packham, G. (1998). BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16, 1803-1812.
10. Chaouchi, N., Arvanitakis, L., Auffredou, M. T., Blanchard, D. A., Vazquez, A. & Sharma, S. (1995). Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11, 1615-1622.
11. Cryns, V. & Yuan, J. (1998). Proteases to die for. Genes & Development 12, 1551-1570.
12. Derynck, R. & Feng, X. H. (1997). TGF-beta receptor signaling. Biochimica et Biophysica Acta 1333, F105-F150.
13. di Renzo, L., Altiok, A., Klein, G. & Klein, E. (1994). Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. International Journal of Cancer 57, 914-919.
14. Douglas, R. S., Capocasale, R. J., Lamb, R. J., Nowell, P. C. & Moore, J. S. (1997). Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood 89, 941-947.
15. Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H. & Crook, T. (1991). p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO Journal 10, 2879-2887.
16. Feng, X. H. & Derynck, R. (1996). Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. Journal of Biological Chemistry 271, 13123-13129.
17. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H. & Miyazono, K. (1993). Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75, 681-692.
18. + T cells. Journal of Immunology 148, 2291-2299.
19. Gilboa, L., Wells, R. G., Lodish, H. F. & Henis, Y. I. (1998). Oligomeric structure of type I and type II transforming growth factor β receptors: homodimers form in the ER and persist at the plasma membrane. Journal of Cell Biology 140, 767-777.
20. Gregory, C. D., Rowe, M. & Rickinson, A. B. (1990). Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Journal of General Virology 71, 1481-1495.
21. Gutierrez, M. I., Cherney, B., Hussain, A., Mostowski, H., Tosato, G., Magrath, I. & Bhatia, K. (1999). Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Research 59, 696-703.
22. Heldin, C.-H., Miyazono, K. & ten Dijke, P. (1997). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
23. Jiang, W., Tillekeratne, M. P. M., Brattain, M. G. & Banerji, S. S. (1997). Decreased stability of transforming growth factor β type II receptor mRNA in RER human colon carcinoma cells. Biochemistry 36, 14786-14793.
24. Kaptein, J. S., Lin, C.-K. E., Wang, C. L., Nguyen, T. T., Kalunta, C. I., Park, E., Chen, F.-S. & Lad, P. M. (1996). Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis. Journal of Biological Chemistry 271, 18875-18884.
25. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T. & Miyazono, K. (1998). Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO Journal 17, 4056-4065.
26. Kehrl, J. H., Taylor, A. S., Delsing, G. A., Roberts, A. B., Sporn, M. B. & Fauci, A. S. (1989). Further studies of the role of transforming growth factor-beta in human B cell function. Journal of Immunology 143, 1868-1074.
27. Kumar, A., Rogers, T., Maizel, A. & Sharma, S. (1991). Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. Journal of Immunology 147, 998-1006.
28. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. & Earnshaw, W. C. (1994). Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
29. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A. & Lodish, H. F. (1992). Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
30. Lomo, J., Blomhoff, H. K., Beiske, K., Stokke, T. & Smeland, E. B. (1995). TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. Journal of Immunology 154, 1634-1643.
31. MacDonald, I., Wang, H., Grand, R., Armitage, R. J., Fanslow, W. C., Gregory, C. D. & Gordon, J. (1996). Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines. Blood 87, 1147-1154.
32. Mann, K. P., Staunton, D. & Thorley-Lawson, D. A. (1985). Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. Journal of Virology 55, 710-720.
33. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B. and others (1995). Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338
34. Massagué, J. (1998). TGF-β signal transduction. Annual Review of Biochemistry 67, 753-791.
35. Milner, A. E., Grand, R. J., Vaughan, A. T., Armitage, R. J. & Gregory, C. D. (1997). Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation. Oncogene 15, 1815-1822.
36. Milner, A. E., Levens, J. M. & Gregory, C. D. (1998). Flow cytometric methods of analyzing apoptotic cells. Methods in Molecular Biology 80, 347-354.
37. Pokrovskaja, K., Ehlin-Henriksson, B., Bartkova, J., Bartek, J., Scuderi, R., Szekely, L., Wiman, K. G. & Klein, G. (1996). Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Cell Growth and Differentiation 7, 1723-1732.
38. Polyak, K. (1996). Negative regulation of cell growth by TGF beta. Biochimica et Biophysica Acta 1242, 185-199.
39. Rich, B. E. & Steitz, J. A. (1987). Human acidic ribosomal phosphoproteins P0, P1, and P2 : analysis of cDNA clones, in vitro synthesis, and assembly. Molecular and Cellular Biology 7, 4065-4074.
40. Rickinson, A. B. & Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, 3rd edn, pp. 2397-2446. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
41. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H. & Rickinson, A. B. (1987). Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO Journal 6, 2743-2751.
42. Saltzman, A., Munro, R., Searfoss, G., Franks, C., Jaye, M. & Ivashchenko, Y. (1998). Transforming growth factor-β-mediated apoptosis in Ramos B-lymphoma cell line is accompanied by caspase activation and BclXI downregulation. Experimental Cell Research 242, 244-254.
43. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
44. Schrantz, N., Blanchard, D. A., Auffredou, M. T., Sharma, S., Leca, G. & Vazquez, A. (1999). Role of caspases and possible involvement of retinoblastoma protein during TGFβ-mediated apoptosis of human B lymphoblasts. Oncogene 18, 3511-3519.
45. Schuster, C., Chasserot-Golaz, S. & Beck, G. (1991). Activation of Epstein-Barr virus promoters by a growth-factor and a glucocorticoid. FEBS Letters 284, 82-86.
46. Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Huffman, B. & Liebermann, D. (1994). Immediate early up-regulation of bax expression by p53 but not TGF beta 1 : a paradigm for distinct apoptotic pathways. Oncogene 9, 1791-1798.
47. Smeland, E. B., Blomhoff, H. K., Holte, H., Ruud, E., Beiske, K., Funderud, S., Godal, T. & Ohlsson, R. (1987). Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Experimental Cell Research 171, 213-222.
48. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F. & Taketo, M. M. (1998). Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656.
49. Takenoshita, S., Hagiwara, K., Nagashima, M., Gemma, A., Bennett, W. P. & Harris, C. C. (1996). The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII). Genomics 36, 341-344.
50. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. (1998). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373-1381.
51. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. & Massagué, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
52. Zhu, Y., Richardson, J. A., Parada, L. F. & Graff, J. M. (1998). Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714.